1. Home
  2. ALIS vs CPIX Comparison

ALIS vs CPIX Comparison

Compare ALIS & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ALIS

Calisa Acquisition Corp Ordinary shares

N/A

Current Price

$10.17

Market Cap

85.6M

Sector

N/A

ML Signal

N/A

Logo Cumberland Pharmaceuticals Inc.

CPIX

Cumberland Pharmaceuticals Inc.

HOLD

Current Price

$5.89

Market Cap

92.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALIS
CPIX
Founded
2024
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
85.6M
92.3M
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
ALIS
CPIX
Price
$10.17
$5.89
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
32.0K
43.0K
Earning Date
01-01-0001
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
58.70
EPS
N/A
N/A
Revenue
N/A
$42,010,949.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
16.75
52 Week Low
$9.87
$1.85
52 Week High
$10.25
$7.36

Technical Indicators

Market Signals
Indicator
ALIS
CPIX
Relative Strength Index (RSI) 65.26 48.03
Support Level $10.05 $5.42
Resistance Level N/A $6.04
Average True Range (ATR) 0.04 0.49
MACD 0.00 -0.08
Stochastic Oscillator 50.00 18.33

Price Performance

Historical Comparison
ALIS
CPIX

About ALIS Calisa Acquisition Corp Ordinary shares

Calisa Acquisition Corp is a blank check company with the purpose of effecting a merger, asset acquisition, stock exchange, stock purchase, reorganization, or similar business combination.

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.

Share on Social Networks: